T1	Source 9 26	G.D. Searle & Co.
T2	Cue 27 31	said
T3	Content 32 179	the Food and Drug Administration approved the sale of Kerlone, a hypertension drug developed by a joint venture between Searle and a French concern
T4	Attribution 27 31	said
E1	Attribution:T4 Content:T3 Cue:T2 Source:T1
T5	Source 183 214	Searle, a unit of Monsanto Co.,
T6	Cue 215 219	said
T7	Content 220 463	the "beta-blocker" high-blood-pressure drug Kerlone is the first product to reach the market through Lorex Pharmaceuticals, the U.S. company jointly owned by Searle and Synthelabo, a French pharmaceutical concern owned by France's L'Oreal S.A.
T8	Attribution 215 219	said
E2	Attribution:T8 Content:T7 Cue:T6 Source:T5
